瑞康医药：公司董事、董事会秘书及副总裁李喆解除留置并变更为责令候查

Group 1 - The company, Ruikang Pharmaceutical (002589.SZ), announced that it received a notice from the Jinan Jiuyang District Supervisory Committee on August 12, 2025, regarding the change of detention measures for Li Zhe, which has been lifted and replaced with a directive for supervision [1] - The company's production and operational status is currently normal, and Li Zhe is able to perform his duties normally [1]